MedPath

utrition, growth and development among very preterm infants - PRE

Conditions
The main purpose of this study is to evaluate the effect of increased supply of energy, protein, vitamin A and the long chain polyunsaturated fatty acids DHA and AA to Very Low Birth Weight Infants (VLBW,birth weight below 1500 grams) on 1) growth2)brain maturation3)cognitive function4)morbidity such as retinopathy of prematurity, bronchopulmonary dysplasia, periventricular leucomalacia, necrotizing enterocolitis, sepsis.5)mortality (defined as percent dead before hospital discharge).
Registration Number
EUCTR2010-020464-38-NO
Lead Sponsor
niversity of Oslo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
240
Inclusion Criteria

Infants born at Oslo University Hospital and Akershus University Hospital with birth weight < 1500 grams are eligible.
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Exclusion criteria are congenital malformations, chromosomal abnormalities and clinical syndromes known to affect growth, and critical illness with short life expectancy.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath